Market Closed -
Bombay S.E.
06:19:49 2024-05-10 EDT
|
5-day change
|
1st Jan Change
|
129
INR
|
+0.19%
|
|
-1.64%
|
-14.60%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,292
|
2,333
|
3,884
|
8,866
|
9,976
|
5,419
|
Enterprise Value (EV)
1 |
2,634
|
2,613
|
4,082
|
9,002
|
10,028
|
5,324
|
P/E ratio
|
19.5
x
|
16.8
x
|
18.8
x
|
32.3
x
|
31.3
x
|
68.5
x
|
Yield
|
0.33%
|
0.66%
|
0.46%
|
0.26%
|
0.28%
|
0.52%
|
Capitalization / Revenue
|
0.77
x
|
0.76
x
|
1.04
x
|
2.33
x
|
2.04
x
|
1.26
x
|
EV / Revenue
|
0.88
x
|
0.85
x
|
1.1
x
|
2.37
x
|
2.06
x
|
1.24
x
|
EV / EBITDA
|
12.1
x
|
10.9
x
|
12.6
x
|
22.7
x
|
22.2
x
|
38.8
x
|
EV / FCF
|
38.6
x
|
82.1
x
|
54
x
|
278
x
|
212
x
|
45.2
x
|
FCF Yield
|
2.59%
|
1.22%
|
1.85%
|
0.36%
|
0.47%
|
2.21%
|
Price to Book
|
6.47
x
|
4.83
x
|
5.76
x
|
9.54
x
|
8.15
x
|
4.26
x
|
Nbr of stocks (in thousands)
|
51,000
|
51,000
|
51,000
|
51,000
|
51,000
|
51,000
|
Reference price
2 |
44.95
|
45.75
|
76.15
|
173.8
|
195.6
|
106.2
|
Announcement Date
|
18-08-13
|
19-08-23
|
20-09-07
|
21-09-07
|
22-09-07
|
23-09-07
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,977
|
3,087
|
3,726
|
3,798
|
4,879
|
4,304
|
EBITDA
1 |
218.3
|
239.9
|
323.5
|
395.7
|
451.8
|
137.4
|
EBIT
1 |
194.8
|
219.1
|
302.3
|
372.7
|
428
|
109.6
|
Operating Margin
|
6.54%
|
7.1%
|
8.11%
|
9.81%
|
8.77%
|
2.55%
|
Earnings before Tax (EBT)
1 |
161.9
|
193.6
|
273.2
|
367.9
|
429.9
|
109.5
|
Net income
1 |
117.5
|
138.9
|
206.7
|
274.4
|
319
|
79.19
|
Net margin
|
3.95%
|
4.5%
|
5.55%
|
7.23%
|
6.54%
|
1.84%
|
EPS
2 |
2.300
|
2.723
|
4.050
|
5.380
|
6.250
|
1.550
|
Free Cash Flow
1 |
68.19
|
31.82
|
75.56
|
32.41
|
47.38
|
117.7
|
FCF margin
|
2.29%
|
1.03%
|
2.03%
|
0.85%
|
0.97%
|
2.73%
|
FCF Conversion (EBITDA)
|
31.23%
|
13.26%
|
23.35%
|
8.19%
|
10.49%
|
85.66%
|
FCF Conversion (Net income)
|
58.03%
|
22.91%
|
36.55%
|
11.81%
|
14.85%
|
148.59%
|
Dividend per Share
2 |
0.1500
|
0.3000
|
0.3500
|
0.4500
|
0.5500
|
0.5500
|
Announcement Date
|
18-08-13
|
19-08-23
|
20-09-07
|
21-09-07
|
22-09-07
|
23-09-07
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
342
|
280
|
199
|
136
|
52.8
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
94.5
|
Leverage (Debt/EBITDA)
|
1.565
x
|
1.168
x
|
0.614
x
|
0.3428
x
|
0.1168
x
|
-
|
Free Cash Flow
1 |
68.2
|
31.8
|
75.6
|
32.4
|
47.4
|
118
|
ROE (net income / shareholders' equity)
|
38.6%
|
33.1%
|
35.7%
|
34.2%
|
29.6%
|
6.35%
|
ROA (Net income/ Total Assets)
|
11.4%
|
12.8%
|
15.1%
|
16.2%
|
16.6%
|
4.05%
|
Assets
1 |
1,035
|
1,088
|
1,371
|
1,699
|
1,924
|
1,956
|
Book Value Per Share
2 |
6.950
|
9.480
|
13.20
|
18.20
|
24.00
|
24.90
|
Cash Flow per Share
2 |
0.2400
|
0.3500
|
0.5800
|
0.6200
|
1.660
|
1.730
|
Capex
1 |
4.68
|
10.9
|
76.6
|
59.8
|
64.3
|
56.1
|
Capex / Sales
|
0.16%
|
0.35%
|
2.06%
|
1.58%
|
1.32%
|
1.3%
|
Announcement Date
|
18-08-13
|
19-08-23
|
20-09-07
|
21-09-07
|
22-09-07
|
23-09-07
|
|
1st Jan change
|
Capi.
|
---|
| -14.60% | 78.73M | | +1.61% | 49.2B | | +16.33% | 41.24B | | +18.68% | 25.89B | | +12.78% | 19.81B | | +0.85% | 17.48B | | -21.87% | 15.86B | | +2.32% | 15.35B | | -10.29% | 15.23B | | -22.30% | 13.36B |
Other Specialty Chemicals
|